Status:
COMPLETED
Effectiveness of Ultrasound Guided Hydro-dissection of Median Nerve in Carpal Tunnel Syndrome
Lead Sponsor:
Ain Shams University
Collaborating Sponsors:
Ahmed ElSadek
Iman Hamed
Conditions:
Carpal Tunnel Syndrome
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
60 patients with carpal tunnel syndrome will undergo ultrasound guided hydrodissection of the median nerve with follow up using Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) at 3, 6 and 12 months
Detailed Description
Aim of study: to evaluate the effectiveness of ultrasound guided hydrodissection of median nerve as minimal invasive procedure in carpal tunnel syndrome Study Design: 60 patients with a clinical di...
Eligibility Criteria
Inclusion
- patients with clinical diagnosis of mild to moderate CTS and confirmed by neurophysiological studies.
- The clinical symptoms and signs of CTS are as follows:
- sensory symptoms in the form of paresthesia, dysesthesia, pain and numbness of the hand in the distribution of median nerve which was more nocturnal, postural or related to hand overuse and relieved by frequent shaking of the hand
- motor symptoms in the form of decreased strength of the thenar muscles
- positive Phalen and/or Tinel sign.
Exclusion
- Pregnancy
- Cancer
- hypothyroidism
- systemic infection
- history of polyneuropathy
- cervical radiculopathy
- brachial plexopathy
- thoracic outlet syndrome
- history of previous carpal tunnel open surgery or local steroid injection and severe CTS (confirmed by el electrophysiological studies)
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 6 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05204992
Start Date
April 1 2022
End Date
July 6 2023
Last Update
February 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine Ain Shams University
Cairo, Egypt